Correspondence 0001493152-25-001923 from Aspire Biopharma Holdings, Inc. (ASBP)

Aspire Biopharma Holdings, Inc.
Date: Jan. 13, 2025 · CIK: 0001847345 · Accession: 0001493152-25-001923

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-281991

Date

Jan. 13, 2025

Author

Chief

Form

CORRESP

Company

Aspire Biopharma Holdings, Inc.

Letter

Aspire Biopharma, Inc.

Candelaro Drive, #233

Humacao, Puerto Rico 00791

Tel: (415) 592-7399

January 13, 2025

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporate Finance

Office of Life Sciences

F Street, N.E.

Washington, D.C. 20549

Attention: Tyler Hawes

Re: PowerUp Acquisition Corp.

Registration Statement on Form S-4

File No. 333-281991

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time on January 14, 2025, or as soon thereafter as practicable.

Please contact Arthur Marcus, Esq. of Sichenzia Ross Ference Carmel LLP at (516) 459-8161, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.

Very
truly yours,
Aspire
Biopharma, Inc.

Show Raw Text

CORRESP
1
filename1.htm

Aspire
Biopharma, Inc.

194
Candelaro Drive, #233

Humacao,
Puerto Rico 00791

Tel: (415)
592-7399

  January
13, 2025

VIA
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporate Finance

Office
of Life Sciences

100
F Street, N.E.

Washington,
D.C. 20549

Attention:
Tyler Hawes

    Re:
    PowerUp Acquisition Corp.

    Registration
    Statement on Form S-4

    File
    No. 333-281991

Ladies
and Gentlemen:

Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for
the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time on January
14, 2025, or as soon thereafter as practicable.

Please
contact Arthur Marcus, Esq. of Sichenzia Ross Ference Carmel LLP at (516) 459-8161, as soon as the Registration Statement has been declared
effective, or if you have any other questions or concerns regarding this matter.

    Very
    truly yours,

    Aspire
    Biopharma, Inc.

    By:

    /s/
    Kraig Higginson

    Kraig
    Higginson

    Chief
    Executive Officer

SecProbe.io